The Reimbursement News section of BJH systematically covers all new haematology drugs that have recently become available in Belgium, including a short description of the reimbursement modalities. Changes in the reimbursement criteria of haematology drugs are also listed. Please find below an overview of the most recent drug reimbursements in haematology!
More detailed reimbursement criteria/information can be consulted on the website of RIZIV/INAMI.
Top
